{{Rsnum
|rsid=2270875
|Gene=EFR3A
|Chromosome=8
|position=131987689
|Orientation=minus
|GMAF=0.1079
|Gene_s=EFR3A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.1 | 20.0 | 76.9
| HCB | 2.2 | 46.7 | 51.1
| JPT | 2.3 | 29.5 | 68.2
| YRI | 0.0 | 3.2 | 96.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.2 | 46.7 | 51.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 45.0 | 55.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23374588
  |Trait=Response to cholinesterase inhibitors in Alzheimer's disease
  |Title=Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.
  |RiskAllele=G
  |Pval=9E-6
  |OR=2.84
  |ORtxt=[NR] unit decrease
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}